Korean J Pain.  2018 Jul;31(3):183-190. 10.3344/kjp.2018.31.3.183.

A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy

Affiliations
  • 1Department of Pharmacology, IPGME&R, Kolkata, India. drsilamrita@gmail.com
  • 2Department of Neuromedicine, Institute of Neurosciences, Kolkata, India.
  • 3Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex, Mumbai, India.

Abstract

BACKGROUND
Vitamin B12 deficiency has been associated with peripheral neuropathy, loss of sensation in the peripheral nerves, and weakness in the lower extremities. Methylcobalamin is the most effective analogue of vitamin B12 used to treat or prevent the complications associated with vitamin B12 deficiency. The current study aimed to compare the serum cobalamin levels after administration of two different regimes of methylcobalamin in peripheral neuropathy patients.
METHODS
The present study was a prospective, randomized, comparative study. The study consisted of two parallel groups, group A (methylcobalamin 500 µg injection intramuscularly three times a week) and group B (methylcobalamin 1500 µg injection intramuscularly once a week). A control group of healthy volunteers was also included.
RESULTS
A total of 24 patients (12 in each group) were included in the study. Five healthy volunteers were also included as a control in each group. At the end of treatment, serum cobalamin levels were significantly (P = 0.028) higher in group A (1892.08 ± 234.50) as compared with group B (1438.5 ± 460.32). The serum cobalamin levels in Group A healthy volunteers were also two times higher than that of group B (P = 0.056). Both the LANSS scale and DN4 questionnaire reported similar results at end of treatment.
CONCLUSIONS
The 500 µg methylcobalamin thrice weekly regime is more effective in increasing the serum cobalamin levels as compared to the 1500 µg methylcobalamin once weekly regime.

Keyword

Clinical protocols; Cobalamin (vitamin B12); Drug dose-response relationship; Intramuscular injection; Methylcobalamin; Neuropathic pain; Peripheral neuropathy; Prospective studies; Randomized controlled clinical trials; Survey and questionnaire; Vitamin B12 deficiency

MeSH Terms

Clinical Protocols
Dose-Response Relationship, Drug
Healthy Volunteers
Humans
Injections, Intramuscular
Lower Extremity
Neuralgia
Peripheral Nerves
Peripheral Nervous System Diseases*
Prospective Studies
Sensation
Vitamin B 12 Deficiency
Vitamin B 12*
Vitamin B 12

Figure

  • Fig. 1 Study disposition chart.

  • Fig. 2 Changes in serum cobalamin levels in patients and healthy volunteers.


Reference

1. Zagar BR, Longyhore DS. Evaluating the association between vitamin B12 deficiency and peripheral neuropathy in patients with diabetes. Int J Med Pharm. 2014; 2:1–10.
Article
2. Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients. 2013; 5:4521–4539. PMID: 24248213.
Article
3. Oh R, Brown DL. Vitamin B12 deficiency. Am Fam Physician. 2003; 67:979–986. PMID: 12643357.
4. Leishear K, Boudreau RM, Studenski SA, Ferrucci L, Rosano C, de Rekeneire N, et al. Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults. J Am Geriatr Soc. 2012; 60:1057–1063. PMID: 22690982.
Article
5. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991; 70:229–245. PMID: 1648656.
Article
6. Soneji N, Peng PW. Ultrasound-guided pain interventions - a review of techniques for peripheral nerves. Korean J Pain. 2013; 26:111–124. PMID: 23614071.
Article
7. McCombe PA, McLeod JG. The peripheral neuropathy of vitamin B12 deficiency. J Neurol Sci. 1984; 66:117–126. PMID: 6097649.
Article
8. Amador N. Vitamin B12 replacement therapy and its rehabilitative effects on psychiatric and neurologic symptoms. Nutrition Bytes. 1998; 4.
9. Aaron S, Kumar S, Vijayan J, Jacob J, Alexander M, Gnanamuthu C. Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India. 2005; 53:55–58. PMID: 15805657.
Article
10. Gupta JK. A review on hyperhomocysteinemia and its risk factors. Innovare J Med Sci. 2016; 4:11–14.
11. Mizukami H, Ogasawara S, Yamagishi S, Takahashi K, Yagihashi S. Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats. Eur J Clin Invest. 2011; 41:442–450. PMID: 21128935.
Article
12. Mutiawati E, Meliala L, Aji D, Wasito W, Muchlisin ZA. A preliminary study on the effect of methylcobalamin application on reducing neuropathic pain. HVM Bioflux. 2015; 7:101–103.
13. Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg. 1992; 94:105–111. PMID: 1324807.
Article
14. Yamane K, Usui T, Yamamoto T, Tsukamoto T, Soma Y, Yoshimura N, et al. Clinical efficacy of intravenous plus oral mecobalamin in patients with peripheral neuropathy using vibration perception thresholds as an indicator of improvement. Curr Ther Res Clin Exp. 1995; 56:656–670.
Article
15. Chatterjee S, Dureja GP, Kadhe G, Mane A, Phansalkar AA, Sawant S, et al. Cross-sectional study for prevalence of non-steroidal anti-inflammatory drug-induced gastrointestinal, cardiac and renal complications in India: interim report. Gastroenterology Res. 2015; 8:216–221. PMID: 27785299.
Article
16. Bennett M. The LANSS Pain Scale: the leeds assessment of neuropathic symptoms and signs. Pain. 2001; 92:147–157. PMID: 11323136.
Article
17. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005; 114:29–36. PMID: 15733628.
Article
18. Kennedy DO. B vitamins and the brain: Mechanisms, dose and efficacy—A review. Nutrients. 2016; 8:68. PMID: 26828517.
Article
19. Scalabrino G, Buccellato FR, Veber D, Mutti E. New basis of the neurotrophic action of vitamin B12. Clin Chem Lab Med. 2003; 41:1435–1437. PMID: 14656022.
Article
20. Scalabrino G, Corsi MM, Veber D, Buccellato FR, Pravettoni G, Manfridi A, et al. Cobalamin (vitamin B(12)) positively regulates interleukin-6 levels in rat cerebrospinal fluid. J Neuroimmunol. 2002; 127:37–43. PMID: 12044973.
Article
21. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press;1998.
22. Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, et al. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp Neurol. 2010; 222:191–203. PMID: 20045411.
Article
23. Package insert template for mecobalamin tablet & capsule [Internet]. Petaling Jaya, Malaysia: Idaman Pharma;2013. cited 2016 Sep 5. Available at http://npra.moh.gov.my/images/reg-and-noti/PI/non-poison/Mecobalamin-Template-oral-Website.pdf.
24. Watanabe T, Kaji R, Oka N, Bara W, Kimura J. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci. 1994; 122:140–143. PMID: 8021696.
Article
25. Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med. 1999; 38:472–475. PMID: 10411351.
Article
26. Minauchi Y, Tokunaga H, Suzuki M. Leprous neuralgic pain--its therapy and pathogenesis. Nihon Rai Gakkai Zasshi. 1986; 55:210–217. PMID: 3429365.
27. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Amelioration by mecobalamin of subclinical carpal tunnel syndrome involving unaffected limbs in stroke patients. J Neurol Sci. 2005; 231:13–18. PMID: 15792815.
Article
28. Yagihashi S, Tokui A, Kashiwamura H, Takagi S, Imamura K. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats. Horm Metab Res. 1982; 14:10–13. PMID: 6460676.
Article
29. Yamazaki K, Oda K, Endo C, Kikuchi T, Wakabayashi T. Methylcobalamin (methyl-B12) promotes regeneration of motor nerve terminals degenerating in anterior gracile muscle of gracile axonal dystrophy (GAD) mutant mouse. Neurosci Lett. 1994; 170:195–197. PMID: 8041506.
Article
30. Naik SU, Sonawane DV. Methylcobalamin is effective in peripheral neuropathies. Eur J Clin Nutr. 2015; 69:530. PMID: 25585598.
Article
31. Monograph. Altern Med Rev. 1998; 3:461–463. PMID: 9855571.
32. Methylcobalamin (Vitamin B-12) Injection [Internet]. Tampa (FL): Defy Medical;cited 2016 Sep 9. Available at http://www.defymedical.com/services/12-services/89-methylcobalamin-vitamin-b-12-injection.
33. Sweetman SC. Martindale: the complete drug reference. 36th ed. London: Pharmaceutical Press;2009.
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr